Gamma Healthcare INC
Gamma Healthcare INC was paid $2.96M by Medicaid between Jan 2018 and Nov 2020, across 114 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 15% of everything it billed.
POPLAR BLUFF, MO 63901
Next to other Clinical Medical Laboratory providers in Missouri
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 439,664 | $750K | |
| 2019 | 285,672 | $768K | |
| 2020 | 240,879 | $1.44M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 15% | 7,875 | 4,776 | $431K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 8.6% | 7,857 | 6,256 | $255K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.3% | 88,432 | 69,099 | $245K |
| 80053 | Comprehensive metabolic panel | 7.4% | 59,092 | 51,065 | $219K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.5% | 17,962 | 16,270 | $163K |
| 83036 | Hemoglobin; glycosylated (A1C) | 5.2% | 37,393 | 34,388 | $155K |
| 80061 | Lipid panel | 4.5% | 26,325 | 24,366 | $134K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.3% | 22,271 | 20,759 | $127K |
| 80164 | 2.9% | 13,664 | 12,167 | $87K | |
| 80177 | 2.6% | 9,039 | 7,504 | $76K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 34,555 | 25,741 | $70K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.3% | 6,054 | 5,334 | $67K |
102 more codes
| 87641 | 2.2% | 6,056 | $64K | |
| 87481 | 2.0% | 6,015 | $59K | |
| 87500 | 2.0% | 6,058 | $59K | |
| 80050 | General health panel | 1.9% | 3,640 | $55K |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 44,173 | $55K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.8% | 21,033 | $52K |
| 87186 | 1.4% | 14,689 | $42K | |
| 83880 | 1.4% | 4,947 | $42K | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 1.3% | 114,742 | $38K |
| 82607 | 1.2% | 7,414 | $37K | |
| 87077 | 1.2% | 12,855 | $36K | |
| 80185 | 1.1% | 5,704 | $34K | |
| 82140 | <1% | 4,370 | $28K | |
| 85610 | <1% | 23,138 | $25K | |
| 81001 | <1% | 23,316 | $23K | |
| 83735 | <1% | 7,679 | $20K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 625 | $19K |
| 82746 | <1% | 3,397 | $18K | |
| 84153 | <1% | 1,711 | $15K | |
| 84439 | <1% | 3,207 | $15K | |
| 84134 | <1% | 3,052 | $14K | |
| 80076 | <1% | 3,352 | $12K | |
| 80178 | <1% | 2,393 | $10K | |
| 87070 | <1% | 2,586 | $9K | |
| 80156 | <1% | 1,339 | $9K | |
| 83540 | <1% | 3,766 | $9K | |
| 84436 | <1% | 3,622 | $9K | |
| 82248 | <1% | 5,084 | $8K | |
| 81007 | <1% | 1,080 | $7K | |
| 85027 | <1% | 2,724 | $6K | |
| 83550 | <1% | 2,213 | $6K | |
| 83970 | <1% | 643 | $6K | |
| 80202 | <1% | 688 | $5K | |
| 82550 | <1% | 1,530 | $5K | |
| 82728 | <1% | 1,427 | $5K | |
| 82947 | <1% | 16,493 | $5K | |
| 84479 | <1% | 2,212 | $4K | |
| 87205 | <1% | 2,257 | $4K | |
| 84550 | <1% | 2,406 | $4K | |
| 80184 | <1% | 854 | $4K | |
| 80162 | <1% | 1,368 | $4K | |
| 82274 | <1% | 984 | $4K | |
| 86703 | <1% | 516 | $3K | |
| 86140 | <1% | 1,268 | $3K | |
| 85652 | <1% | 2,155 | $3K | |
| 84100 | <1% | 1,452 | $3K | |
| 84132 | <1% | 16,144 | $3K | |
| 80069 | <1% | 755 | $3K | |
| 80305 | <1% | 408 | $3K | |
| 83690 | <1% | 566 | $2K | |
| 84481 | <1% | 259 | $2K | |
| 82977 | <1% | 310 | $2K | |
| 82150 | <1% | 561 | $2K | |
| 85018 | <1% | 2,001 | $2K | |
| 86592 | <1% | 932 | $2K | |
| 82043 | <1% | 662 | $1K | |
| 83615 | <1% | 291 | $1K | |
| 80175 | <1% | 351 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 25 | $1K |
| 85014 | <1% | 1,917 | $1K | |
| 82565 | <1% | 14,209 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 239 | $1K |
| 84520 | <1% | 13,965 | $906.03 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 156 | $885.06 |
| 84295 | <1% | 13,488 | $796.86 | |
| 87045 | <1% | 136 | $668.46 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 224 | $554.88 |
| 87899 | <1% | 197 | $430.24 | |
| 82040 | <1% | 8,335 | $414.13 | |
| 86769 | <1% | 12 | $408.57 | |
| 80074 | <1% | 31 | $391.50 | |
| 84460 | <1% | 8,101 | $356.38 | |
| 86787 | <1% | 47 | $257.60 | |
| 82310 | <1% | 13,643 | $256.90 | |
| 84450 | <1% | 8,031 | $245.22 | |
| 86780 | <1% | 59 | $240.51 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 1,767 | $213.93 |
| 83789 | <1% | 40 | $190.08 | |
| 85045 | <1% | 188 | $180.76 | |
| 84075 | <1% | 7,900 | $152.50 | |
| 87015 | <1% | 82 | $145.72 | |
| 85730 | <1% | 58 | $134.11 | |
| 87040 | <1% | 40 | $127.22 | |
| 85379 | <1% | 22 | $119.19 | |
| 82374 | <1% | 13,169 | $110.60 | |
| 84155 | <1% | 7,919 | $102.83 | |
| 86696 | <1% | 13 | $100.62 | |
| 84484 | <1% | 55 | $85.47 | |
| 82570 | <1% | 59 | $84.48 | |
| 80188 | <1% | 32 | $74.73 | |
| 86695 | <1% | 13 | $68.64 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 85,578 | $50.00 |
| 80051 | <1% | 249 | $34.78 | |
| 82465 | <1% | 3,073 | $28.03 | |
| 84478 | <1% | 3,042 | $23.49 | |
| 83718 | <1% | 3,033 | $20.89 | |
| 82247 | <1% | 7,855 | $20.15 | |
| 87276 | <1% | 26 | $12.85 | |
| 87275 | <1% | 26 | $11.84 | |
| 82435 | <1% | 13,141 | $10.00 | |
| 84156 | <1% | 15 | $8.43 | |
| 84146 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Gamma Healthcare INC | Poplar Bluff, MO | $738K |
| Gamma Healthcare, INC | Saint Louis, MO | $598K |
| Gamma Healthcare, INC | Tyler, TX | $270K |
| Gamma Healthcare, INC | Poplar Bluff, MO | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.